Jones Financial Companies’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Jones Financial Companies’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-27	Closed	-$2K	–	767
2022 Q2	$2K	Sell	27 -40	-60%	-$3.79K	﹤0.01%	606
2022 Q1	$7K	Sell	67 -76	-53%	-$7.41K	﹤0.01%	549
2021 Q4	$15K	Buy	143 +96	+204%	+$10.5K	﹤0.01%	510
2021 Q3	$5K	Hold	47	–	–	﹤0.01%	582
2021 Q2	$4K	Hold	47	–	–	﹤0.01%	586
2021 Q1	$4K	Buy	+47	New	+$3.97K	﹤0.01%	691

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Jones Financial Companies's HZNP Position: Q3 2022 in Review

Jones Financial Companies sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 27 shares — an estimated $2K sold.

Jones Financial Companies first reported a position in HZNP in Q1 2021 and held it in 6 quarters. The position peaked at $15K in Q4 2021. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

Jones Financial Companies reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
Jones Financial Companies sold 27 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $2K.
Jones Financial Companies first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 6 quarters.
Jones Financial Companies's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $15K in Q4 2021.
530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Jones Financial Companies's 13F filing for Q3 2022, filed 3 Nov 2022.